Publication:
Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study

dc.contributor.author Kasparian, Nadine en_US
dc.contributor.author Meiser, Bettina en_US
dc.contributor.author Butow, P en_US
dc.contributor.author Job, R en_US
dc.contributor.author Mann, G en_US
dc.date.accessioned 2021-11-25T12:58:26Z
dc.date.available 2021-11-25T12:58:26Z
dc.date.issued 2007 en_US
dc.description.abstract Introduction: The potential role of genetic testing in families with an inherited pattern of melanoma is a complex issue, and yet limited data exist on perceptions of predictive genetic testing for mutations among individuals at high risk of melanoma. Methodology: Forty semi-structured interviews were undertaken with affected and unaffected individuals at either high or average risk of developing melanoma due to family history. Interviews addressed key issues such as: the role of genetics in causal attributions for melanoma; genetic testing intentions and motivations; perceived accuracy of genetic testing in predicting melanoma onset, and the impact of varied accuracy on testing intentions; views on the testing of children; perceived benefits and limitations of testing; and information needs and communication preferences. Results: In-depth thematic analysis revealed a number of important qualitative differences between groups at varying risk of melanoma, and genders. Specifically, participants with a family history of melanoma believed genetic factors play an important role in melanoma causation; conveyed strong intentions to pursue genetic testing; and viewed the benefits of genetic testing as outweighing the limitations. Females appeared to endorse the testing of children more firmly than males, and males` intentions to pursue testing appeared more contingent on penetrance than females`. Across groups, the most preferred communication option was an informational video. Conclusion: Those at high risk of melanoma due to family history express a strong interest in predictive genetic testing. Copyright (C) 2006 John Wiley & Sons, Ltd. en_US
dc.identifier.issn 1057-9249 en_US
dc.identifier.uri http://hdl.handle.net/1959.4/38817
dc.language English
dc.language.iso EN en_US
dc.rights CC BY-NC-ND 3.0 en_US
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/3.0/au/ en_US
dc.source Legacy MARC en_US
dc.subject.other familial melanoma en_US
dc.subject.other predictive genetic testing en_US
dc.subject.other attitudes and en_US
dc.subject.other intentions en_US
dc.subject.other cancer en_US
dc.subject.other oncology en_US
dc.title Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study en_US
dc.type Journal Article en
dcterms.accessRights metadata only access
dspace.entity.type Publication en_US
unsw.accessRights.uri http://purl.org/coar/access_right/c_14cb
unsw.identifier.doiPublisher http://dx.doi.org/10.1002/pon.1052 en_US
unsw.relation.faculty Medicine & Health
unsw.relation.ispartofissue 1 en_US
unsw.relation.ispartofjournal Psycho-Oncology: Journal of the psychological, social and behavioural dimensions of cancer en_US
unsw.relation.ispartofpagefrompageto 69-78 en_US
unsw.relation.ispartofvolume 16 en_US
unsw.relation.originalPublicationAffiliation Kasparian, Nadine, Prince of Wales Clinical School, Faculty of Medicine, UNSW en_US
unsw.relation.originalPublicationAffiliation Meiser, Bettina, Prince of Wales Clinical School, Faculty of Medicine, UNSW en_US
unsw.relation.originalPublicationAffiliation Butow, P en_US
unsw.relation.originalPublicationAffiliation Job, R en_US
unsw.relation.originalPublicationAffiliation Mann, G en_US
unsw.relation.school Clinical School Prince of Wales Hospital *
Files
Resource type